HIGGINS JACK (Chief Scientific Officer) sold 30.0% of their position (9.44K shares) of IMMUNOME INC. on the open market
Open‑market sale worth $204.2K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/3/2026ACC: 0001993684-26-000004
Officer· Chief Scientific Officer
Since Oct 2023
-9.44K
Net shares
Net seller
$204.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
9.44K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−9.44K
Price / share
$21.64
Trade value
$204.24K
% of position
30.0%
4/2/2026
31.44K→22K
Total
Net shares
−9.44K
Net value
-$204.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/2/2026 | S · Sale | −9.44K | $21.64 | $204.24K | 30.0% | 31.44K | 22K |
| Total | −9.44K | -$204.24K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned1K
Common Stock
IndirectShares owned1K
Common Stock
IndirectShares owned1K
Total
3K indirect3K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1K | Indirect |
| Common Stock | 1K | Indirect |
| Common Stock | 1K | Indirect |
| Total | 3K | 3K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported